|
Volumn 69, Issue 12, 2011, Pages 1817-1818
|
The status of Tsukuba BNCT trial: BPA-based boron neutron capture therapy combined with X-ray irradiation
|
Author keywords
Chemotherapy; Glioma; Radiation; Temozolomide; X ray
|
Indexed keywords
BORON NEUTRON CAPTURE THERAPY;
END POINTS;
GLIOMA;
OVERALL SURVIVAL;
PHASE II;
TEMOZOLOMIDE;
X RAY IRRADIATION;
BORON;
BORON COMPOUNDS;
CHEMOTHERAPY;
TUMORS;
X RAYS;
NEUTRON IRRADIATION;
4 BORONOPHENYLALANINE;
BOROCAPTATE;
CARBON 11;
FLUORINE 18;
TEMOZOLOMIDE;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL EFFECTIVENESS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
DRUG UPTAKE;
ERYTHEMA;
GLIOBLASTOMA;
HUMAN;
MULTIPLE CYCLE TREATMENT;
NEUTRON CAPTURE THERAPY;
ORBIT TUMOR;
OVERALL SURVIVAL;
PHASE 2 CLINICAL TRIAL;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
RADIATION DOSE;
X IRRADIATION;
ANTINEOPLASTIC AGENTS;
BORON NEUTRON CAPTURE THERAPY;
COMBINED MODALITY THERAPY;
DACARBAZINE;
HUMANS;
POSITRON-EMISSION TOMOGRAPHY;
|
EID: 80055069979
PISSN: 09698043
EISSN: 18729800
Source Type: Journal
DOI: 10.1016/j.apradiso.2011.02.013 Document Type: Article |
Times cited : (30)
|
References (4)
|